Medtronic (MDT) Change in Accured Expenses (2014 - 2026)

Medtronic's Change in Accured Expenses history runs 13 years deep, the most recent figure standing at $703.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 27.82% year-over-year to $703.0 million; the TTM figure through Jan 2026 stood at $289.0 million (down 40.66% YoY), while the FY2025 annual figure was $209.0 million, down 46.55% from the prior year.
• Change in Accured Expenses came in at $703.0 million for Q1 2026 at Medtronic, up from -$182.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $703.0 million in Q1 2026 to a low of -$673.0 million in Q3 2023.
• A 5-year average of $110.5 million and a median of $177.0 million in 2023 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 10250.0% in 2022 and tumbled 357.82% in 2023, its largest moves.
• Medtronic's Change in Accured Expenses stood at $133.0 million in 2022, then sank by 119.55% to -$26.0 million in 2023, then tumbled by 296.15% to -$103.0 million in 2024, then plunged by 76.7% to -$182.0 million in 2025, then surged by 486.26% to $703.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $703.0 million, -$182.0 million, and -$598.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison